Medical devices, healthcare technology and the business of care
510(k) clearance · K260278

ThermAffyx(TM) Patient Safety System

Stihler Electronic GmbH · Decision date Jul 8, 2026

FDA DECISIONK260278

What did the FDA decide?

FDA records K260278 as a 510(k) premarket notification, with a decision dated Jul 8, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Jul 8, 2026

FDA source record

Regulatory record facts

Identifier
K260278
Regulatory pathway
510(k) premarket notification
Product code
DWJ
Decision code
SESE
Decision date
Jul 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Thermal Regulating.

Product code
DWJ
FDA device class
2

FDA decision timeline

  1. K260278 received

    Application receipt date recorded by FDA.

  2. K260278 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DWJ

Product / regulatory recordCompanyPathwayDecision dateSource
Medivance, Inc.510(k) clearanceOct 30, 2026FDA
Hangzhou Tappa Medical Technology Co., Ltd.510(k) clearanceAug 21, 2026FDA
The Surgical Company International B.V., doing business as TSC Life510(k) clearanceAug 7, 2026FDA
XODUS MEDICAL, INC.510(k) clearanceApr 16, 2026FDA
Hangzhou Tappa Medical Technology Co., Ltd.510(k) clearanceApr 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Stihler Electronic GmbH

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Leinfelden-Echterdingen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records